FindTrial
Sign In

Effect of merocel insertion and modified nasal tube fixation to prevent nasal alar tube necrosis

Utility of merocel insertion and modified tube fixation to prevent nasal alar necrosis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/08/035716
Enrollment
100
Registered
2021-08-17
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C00-C14- Malignant neoplasms of lip, oral cavity and pharynx

Interventions

Intervention1: Group M: merocel will be inserted and packed as a cushion between the outer surface of NTT and nasal mucosa over the alae, before fixing with dynaplast. Intervention2: Group T: along wi

Sponsors

Rajiv Gandhi cancer institute and research centre rohini
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients Undergoing surgery for oral and maxillofacial carcinoma with naso tracheal intubation and the Surgery is expected to be >4hrs

Exclusion criteria

Exclusion criteria: If anticipated duration of nasal intubation is less than 4 hrs

Design outcomes

Primary

MeasureTime frame
Merocel insertion and modified tube fixation with the help of tegaderm will aid in reducing the incidence and severity of alar pressure necrosis after prolonged nasotracheal intubationTimepoint: At extubation—

Secondary

MeasureTime frame
Dermatitis Nasal bleedingTimepoint: At the end of surgery And after extubation—

Countries

India

Contacts

Public ContactDEEPTI GUPTA

Rajiv Gandhi cancer institute and research centre, Rohiniohini

mamcdeepti@gmail.com07065840893

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026